pharma IPO India

• Business

Corona Remedies IPO: Shares Shine On NSE & BSE With 38% Listing Premium, Signaling Strong Investor Confidence On Dalal Street

Corona Remedies debuted strongly on Dalal Street, listing at hefty premiums on NSE and BSE after massive IPO demand, signaling…

• Business

Corona Remedies IPO Opens Strong: High GMP And Long-Term ‘Subscribe’ Rating Boost Investor Interest- Here’s Everything You Need To Know

Corona Remedies IPO opens with strong investor buzz, driven by solid brand strength, high GMP, and long-term growth potential. Though…